Wells Fargo’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $47.7M | Buy |
1,134,658
+157,811
| +16% | +$5.03M | 0.01% | 1055 |
|
|
2026
Q1 | $25.8M | Sell |
976,847
-310,543
| -24% | -$9.09M | ﹤0.01% | 1341 |
|
|
2025
Q4 | $37.3M | Buy |
1,287,390
+290,301
| +29% | +$8.71M | 0.01% | 1099 |
|
|
2025
Q3 | $27.7M | Sell |
997,089
-89,858
| -8% | -$2.27M | 0.01% | 1265 |
|
|
2025
Q2 | $26.5M | Buy |
1,086,947
+153,665
| +16% | +$3.37M | 0.01% | 1218 |
|
|
2025
Q1 | $19.4M | Buy |
933,282
+586,886
| +169% | +$14.7M | ﹤0.01% | 1365 |
|
|
2024
Q4 | $8.16M | Sell |
346,396
-941,829
| -73% | -$23.2M | ﹤0.01% | 2047 |
|
|
2024
Q3 | $33M | Sell |
1,288,225
-3,515
| -0.3% | -$89.5K | 0.01% | 992 |
|
|
2024
Q2 | $30.3M | Sell |
1,291,740
-11,559
| -0.9% | -$292K | 0.01% | 986 |
|
|
2024
Q1 | $37.5M | Buy |
1,303,299
+527,894
| +68% | +$15.9M | 0.01% | 885 |
|
|
2023
Q4 | $25.4M | Sell |
775,405
-498,364
| -39% | -$13.6M | 0.01% | 1030 |
|
|
2023
Q3 | $35.5M | Sell |
1,273,769
-1,478,845
| -54% | -$48.3M | 0.01% | 817 |
|
|
2023
Q2 | $93.8M | Buy |
2,752,614
+277,885
| +11% | +$8.73M | 0.03% | 472 |
|
|
2023
Q1 | $74.4M | Buy |
2,474,729
+201,263
| +9% | +$6.24M | 0.02% | 542 |
|
|
2022
Q4 | $64.2M | Buy |
2,273,466
+1,185,513
| +109% | +$37.6M | 0.02% | 582 |
|
|
2022
Q3 | $35.8M | Buy |
1,087,953
+91,712
| +9% | +$3.37M | 0.01% | 787 |
|
|
2022
Q2 | $31.4M | Sell |
996,241
-18,582
| -2% | -$650K | 0.01% | 893 |
|
|
2022
Q1 | $46.6M | Sell |
1,014,823
-74,990
| -7% | -$3.58M | 0.01% | 822 |
|
|
2021
Q4 | $66.7M | Buy |
1,089,813
+280,528
| +35% | +$19.4M | 0.02% | 662 |
|
|
2021
Q3 | $60.5M | Sell |
809,285
-15,756
| -2% | -$1.32M | 0.01% | 943 |
|
|
2021
Q2 | $76.3M | Sell |
825,041
-186,668
| -18% | -$15.9M | 0.02% | 816 |
|
|
2021
Q1 | $89.8M | Buy |
1,011,709
+396,519
| +64% | +$39.3M | 0.02% | 729 |
|
|
2020
Q4 | $57.4M | Buy |
615,190
+177,673
| +41% | +$14.2M | 0.01% | 905 |
|
|
2020
Q3 | $27.9M | Buy |
437,517
+61,151
| +16% | +$3.58M | 0.01% | 1194 |
|
|
2020
Q2 | $19.6M | Buy |
376,366
+53,259
| +16% | +$2.28M | 0.01% | 1392 |
|
|
2020
Q1 | $10.1M | Buy |
323,107
+42,502
| +15% | +$1.42M | ﹤0.01% | 1657 |
|
|
2019
Q4 | $9.4M | Buy |
280,605
+272,691
| +3,446% | +$8.66M | ﹤0.01% | 2006 |
|
|
2019
Q3 | $234K | Buy |
+7,914
| New | +$257K | ﹤0.01% | 4863 |
|
|
2019
Q2 | – | Sell |
-2,100
| Closed | -$69K | – | 6349 |
|
|
2019
Q1 | $69K | Buy |
2,100
+300
| +17% | +$8.86K | ﹤0.01% | 5251 |
|
|
2018
Q4 | $43K | Hold |
1,800
| – | – | ﹤0.01% | 5566 |
|
|
2018
Q3 | $60K | Hold |
1,800
| – | – | ﹤0.01% | 5538 |
|
|
2018
Q2 | $52K | Buy |
+1,800
| New | +$50.1K | ﹤0.01% | 5578 |
|
|
2015
Q3 | – | Sell |
-50
| Closed | -$1K | – | 6177 |
|
|
2015
Q2 | $1K | Buy |
+50
| New | +$1.16K | ﹤0.01% | 6213 |
|
Other funds holding ARKG
JFG
Wells Fargo's ARKG Position: Q2 2026 in Review
Wells Fargo increased its ARK Genomic Revolution ETF (ARKG) stake by 16% in Q2 2026, buying an estimated $5.03M and bringing the position to 1,134,658 shares worth $47.7M. The position accounts for 0.01% of the portfolio, ranked #1055.
Wells Fargo first reported a position in ARKG in Q2 2015 and has held it in 33 quarters since. The position peaked at $93.8M in Q2 2023. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Wells Fargo held 1,134,658 shares of ARK Genomic Revolution ETF worth $47.7M as of Q2 2026.
- Wells Fargo bought 157,811 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $5.03M.
- ARK Genomic Revolution ETF made up 0.01% of Wells Fargo's portfolio in Q2 2026, its #1055 holding.
- Wells Fargo first reported a position in ARK Genomic Revolution ETF in Q2 2015 and has held it in 33 quarters since.
- Wells Fargo's ARK Genomic Revolution ETF position peaked at $93.8M in Q2 2023.
- 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.